1-4 of 4
Anna Chalmers
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Compartment Effect on the Prognostic Significance of MRD Detection in CLL: Impact of Treatment Type and Duration of Follow-up

Andy C Rawstron, BSc, PhD, Dena Howard, Lucy McParland, Ruth Mary de Tute, PhD FRCPath, Laura Collett, David Phillips, Anna Chalmers, Abraham Mullasseril Varghese, Talha Munir, Walter M Gregory, PhD, Rebecca Bishop, BSc, Francesca J Yates, PhD MSci, Kristian Brock, MSc, BSc, Samuel Muñoz-Vicente, Peter Hillmen
Journal: Blood
Blood (2016) 128 (22): 3226.
https://doi.org/10.1182/blood.V128.22.3226.3226
Published: 2016
Journal Articles

Quadruplet Vs Sequential Triplet Induction Therapy Approaches to Maximise Response for Newly Diagnosed, Transplant Eligible, Myeloma Patients

Charlotte Pawlyn, MB BChir, Faith E Davies, MD, David A Cairns, Corinne Collett, Anna Chalmers, Alina Striha, John R Jones, MD, Mamta Garg, MD, David Allotey, MD, Kamaraj Karunanithi, MBBS, MD, Donald Milligan, MD MBChB, Martin F Kaiser, MD, Matthew W Jenner, MD, Gordon Cook, MD PhD, Nigel H. Russell, MD, Mark T Drayson, MD PhD, Roger G Owen, MD, Walter M Gregory, Graham H Jackson, MD, Gareth J Morgan, MD PhD
Journal: Blood
Blood (2015) 126 (23): 189.
https://doi.org/10.1182/blood.V126.23.189.189
Published: 2015
Journal Articles

The Level of Residual CLL Objectively Predicts the Outcome of Patients Following FCR-Based Therapy with Sequential Benefits per Log Depletion and Improved Post-Treatment Monitoring

Andy C Rawstron, Dena Cohen, Ruth Mary De Tute, Lucy McParland, Laura Collett, David Phillips, Anna Chalmers, Abraham Mullasseril Varghese, Talha Munir, Walter M Gregory, Peter Hillmen
Journal: Blood
Blood (2015) 126 (23): 1717.
https://doi.org/10.1182/blood.V126.23.1717.1717
Published: 2015
Journal Articles

Results Of The Randomised Phase II NCRI Arctic (Attenuated dose Rituximab with ChemoTherapy In CLL) Trial Of Low Dose Rituximab In Previously Untreated CLL

Peter Hillmen, MB ChB, PhD, Donald Milligan, MD, FRCP, FRCPath, Anna Schuh, MD, PhD, Lucy McParland, Anna Chalmers, Tahla Munir, MB ChB, Abraham M Varghese, MB ChB, Andy C Rawstron, BSc, PhD, David J Allsup, MD, PhD, Scott Marshall, MD, Alex Smith, BSc, Corinne Collett, Walter Gregory, PhD, Andrew Duncombe, MD, Dena Cohen, BSc, MSc
Journal: Blood
Blood (2013) 122 (21): 1639.
https://doi.org/10.1182/blood.V122.21.1639.1639
Published: 2013